12616851

Source:http://linkedlifedata.com/resource/pubmed/id/12616851

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0282411, umls-concept:C1707883
pubmed:issue	1
pubmed:dateCreated	2003-3-5
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/12616851-12138603
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9208369
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:issn	1053-8569
pubmed:author	pubmed-author:RawsonNigel S BNS
pubmed:issnType	Print
pubmed:volume	12
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	71-2
pubmed:meshHeading	pubmed-meshheading:12616851-Adverse Drug Reaction Reporting Systems, pubmed-meshheading:12616851-Canada, pubmed-meshheading:12616851-Drug Approval, pubmed-meshheading:12616851-Product Surveillance, Postmarketing
pubmed:articleTitle	Letter to the ISPE commentary editor.
pubmed:affiliation	Center for Health Care Policy and Evaluation, UnitedHealth Group, PO Box 1459, MN008-W109, Minneapolis MN55440-1459, USA. nigel_rawson@uhc.com
pubmed:publicationType	Journal Article, Comment